Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 10.45% is in line with its 5-year average of 9.60%, near the high end of its 5-year range (4.32%–10.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.03% above its 12-month average of 9.49%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.45%.
DEBT TO ASSETS RATIO
10.45%
DEBT TO ASSETS RATIO AVG TTM
9.49%
DEBT TO ASSETS RATIO AVG 3Y
9.56%
DEBT TO ASSETS RATIO AVG 5Y
9.60%
DEBT TO ASSETS RATIO AVG 10Y
9.81%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.03%
CURRENT VS 3Y AVG
+9.23%
CURRENT VS 5Y AVG
+8.77%
CURRENT VS 10Y AVG
+6.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 779 covered companies
CURRENT VS SECTOR MEDIAN
+11506.24%
vs the sector median at left
Quanterix Corporation
Market Cap
$163.22M
Debt to Assets Ratio
10.45%
TTM Avg
9.49%
3Y Avg
9.56%
5Y Avg
9.60%
Market Cap
$161.45M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$159.33M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$170.49M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $163.22M | 10.45% | 9.49% | 9.56% | 9.60% |
| PepGen Inc. (PEPG)vs › | $161.51M | 0.11% | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $161.45M | 0.20% | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $166.26M | 0.12% | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.33M | 0.00% | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $168.85M | 0.22% | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $157.71M | 0.06% | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $169.88M | 0.13% | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | 0.16% | N/A | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $156.53M | 0.66% | N/A | N/A | N/A |
Debt/Assets
10.4%
Debt/Equity
0.14
Current Ratio
3.40
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 10.45% |
| 2026-03-31 | 9.64% |
| 2025-12-31 | 8.89% |
| 2025-09-30 | 9.03% |
| 2025-06-30 | 9.46% |
| 2025-03-31 | 9.18% |
| 2024-12-31 | 9.19% |
| 2024-09-30 | 9.36% |
| 2024-06-30 | 9.62% |
| 2024-03-31 | 9.82% |
| 2023-12-31 | 9.68% |
| 2023-09-30 | 9.88% |
| 2023-06-30 | 10.10% |
| 2023-03-31 | 10.36% |
| 2022-12-31 | 10.17% |
| 2022-09-30 | 9.62% |
| 2022-06-30 | 9.38% |
| 2022-03-31 | 9.01% |
| 2021-12-31 | 4.32% |
| 2021-09-30 | 4.74% |
| 2021-06-30 | 5.73% |
| 2021-03-31 | 5.73% |
| 2020-12-31 | 11.36% |
| 2020-09-30 | 20.56% |
| 2020-06-30 | 18.91% |
| 2020-03-31 | 18.00% |
| 2019-12-31 | 4.51% |
| 2019-09-30 | 4.35% |
| 2019-06-30 | 6.96% |
| 2019-03-31 | 11.73% |
| 2018-12-31 | 11.27% |
| 2018-09-30 | 10.66% |
| 2018-06-30 | 9.78% |
| 2018-03-31 | 10.11% |
| 2017-12-31 | 10.22% |
| 2017-09-30 | 30.57% |
| 2017-06-30 | 26.36% |
| 2017-03-31 | 28.60% |
| 2016-12-31 | 27.60% |
